In Memorium: Tobacco-Control Innovator, Former President of Uruguay, Dr. Tabaré Vázquez Dies from Lung Cancer at 80
Former President of Uruguay and oncologist, Dr. Tabaré Vázquez, died at age 80 from lung cancer on December 6, 2020. He became the first Socialist leader of Uruguay during his […] Read more
Growing Importance and Changing Dynamics: Social Media’s Ever-Changing Role in Thoracic Oncology
H. Jack West, MDAlthough some resist its gravitational pull, social media and especially Twitter are becoming an increasingly valuable tool in academic and community-based cancer care, with thoracic oncology helping set the pace […] Read more
Speaking as a medical oncologist who cares for patients with lung cancer, the present is filled with much hope. There has been a profusion of studies that report increasingly improved […] Read more
A Lack of Standardization in Toxicity Reporting Leaves the Field Open to Misinformation
Emily A. Simons, MD, MPH+more
With many new lung cancer treatments approved through accelerated tracks based on early-phase (I/II) trial data, we have become increasingly aware of the lack of standards for disclosing toxicities when […] Read more
High Risk of Thromboembolic Events in Patients With NSCLC With ALK/ROS1 Fusions
Chuchu Shao, MD+more
The relationship between cancer and thromboembolic events as been widely studied since 1895. As we know, venous thromboembolism (VTE) is a well-recognized complication of malignancy, including pulmonary embolism (PE), deep-vein […] Read more
Physician's Twitter Campaign Boosts UK Quit Smoking Efforts
Conni Bergmann KouryMore than 1 million smokers—and counting—have #QuitforCOVID. Read more
Remotely Monitoring Patients With Cancer Has Applicability During COVID-19 Pandemic and Beyond
Conni Bergmann KouryThe pandemic underscores unmet needs in critical care management and presents an opportunity for learning from patients with cancer. Read more
Decade in Review: Changes in Smoking Behaviors Are Altering the Clinical Picture of Lung Cancer
Kara Nyberg, PhDLung cancer still holds the top position worldwide in terms of the number of new cases and deaths each year, which in 2018 reached 2.1 million and 1.8 million, respectively.1 Given that roughly 85% […] Read more
The Current Role of Combination Maintenance Therapy (Pemetrexed and Bevacizumab) in the Era of Immunotherapy
Yoshimasa Shiraishi+more
Immune checkpoint inhibitors (ICIs) and molecular targeting drugs used against oncogenic drivers, such as EGFR or ALK, have dramatically changed the treatment of NSCLC.1-6 However, treatment options after those drugs […] Read more
Questions Remain Following Long-Term Results of the Phase II SABR-COMET Trial
Ricardo Sales dos Santos, MD, PhDIn Response To: Palma DA, Olson R, Harrow, S, et al. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. […] Read more